Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting
FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy
Flavopiridol Plus Cisplatin Tested In Phase II Trial
Trial Combines Drugs Against Blood Vessel Formation
Bevacizumab And Irinotecan May Increase Survival Of GBM
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation - A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Group chairs propose funding strategy to jump-start correlative studies
- Karen Knudsen to leave ACS
- 2024 Lasker Awards honor discoveries in antitumor immunity, GLP-1-based drugs, and research, advocacy in HIV/AIDS